{"id":53517,"date":"2015-09-14T12:00:55","date_gmt":"2015-09-14T10:00:55","guid":{"rendered":"http:\/\/www.r-biopharm.com\/?p=53517"},"modified":"2019-05-09T09:20:22","modified_gmt":"2019-05-09T07:20:22","slug":"tnf-blocker-medikamenten-monitoring","status":"publish","type":"post","link":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/","title":{"rendered":"TNF\u03b1-Blocker &#038; Medikamenten-Monitoring (de)"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text css=&#8220;.vc_custom_1557386419636{margin-bottom: 0px !important;}&#8220;]<strong>TNF\u03b1-Blocker sind Arzneistoffe, die in der Behandlung von entz\u00fcndlichen Erkrankungen wie Colitis ulcerosa, Morbus Crohn oder Rheuma Anwendung finden. Zu dieser Medikamentengruppe z\u00e4hlen unter anderem die Wirkstoffe Infliximab und Adalimumab.<\/strong><!--more--><\/p>\n<h3>Wie funktionieren TNF\u03b1-Blocker?<\/h3>\n<p>Bei einer einsetzenden Entz\u00fcndung steigern Zellen des Immunsystems die Produktion von TNF\u03b1. TNF\u03b1 bindet an bestimmte Rezeptoren, die wiederum das Signal f\u00fcr den Entz\u00fcndungsprozess ausl\u00f6sen. Bei chronischen Entz\u00fcndungen produziert das Immunsystem kontinuierlich TNF\u03b1, sodass die Entz\u00fcndung best\u00e4ndig aufrechterhalten wird.<\/p>\n<p>TNF\u03b1-Blocker unterbrechen diesen Kreislauf, indem sie an den Botenstoff TNF\u03b1 binden. Dies hat den Effekt, dass das Molek\u00fcl nicht mehr an den Rezeptor binden kann. Der Rezeptor produziert kein Signal zur Aufrechterhaltung des Entz\u00fcndungsprozesses mehr, so dass die Entz\u00fcndung und ihre Symptome abnehmen bzw. aufh\u00f6ren k\u00f6nnen.<\/p>\n<h3>Infliximab und seine Biosimilars<\/h3>\n<p>Infliximab ist ein Medikament, das in der Fachsprache als TNF\u03b1-Blocker bezeichnet wird und zu den sog. Biologicals geh\u00f6rt. Biologicals werden biotechnologisch hergestellt und sind v\u00f6llig oder nahezu mit k\u00f6rpereigenen Proteinen identisch. Sie greifen direkt in den menschlichen Stoffwechsel ein und sind dadurch durch eine hohe Wirksamkeit gekennzeichnet.<\/p>\n<p>Biosimilars sind Folgepr\u00e4parate von Biologicals, deren Patent abgelaufen ist. Ihr Wirkstoff ist vergleichbar mit dem Wirkstoff des bereits zugelassenen biotechnologisch hergestellten Arzneimittels.<\/p>\n<h3>Medikamenten-Monitoring von TNF\u03b1-Blockern<\/h3>\n<p>Um seine optimale Wirkung zu entfalten, ist es wichtig, den Medikamenten-Spiegel von TNF\u03b1-Blockern regelm\u00e4\u00dfig zu \u00fcberpr\u00fcfen, da die Bioverf\u00fcgbarkeit aufgrund von Unterschieden im Stoffwechsel von Mensch zu Mensch unterschiedlich ist. Medikamenten-Monitoring von Infliximab kann z. B. mit dem <a href=\"https:\/\/devclinical.r-biopharm.com\/de\/produkte\/ridascreen-ifx-monitoring-2\/\">RIDASCREEN\u00ae IFX Monitoring<\/a> durchgef\u00fchrt werden.[\/vc_column_text][vc_cta h2=&#8220;Fragen?&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220; add_button=&#8220;right&#8220; btn_title=&#8220;Kontakt&#8220; btn_style=&#8220;flat&#8220; btn_shape=&#8220;square&#8220; btn_color=&#8220;inverse&#8220; btn_link=&#8220;url:mailto%3Aifx%40r-biopharm.de|||&#8220;]Interessiert an weiteren Informationen zum Thema Medikamentenmonitoring? Schreiben Sie uns![\/vc_cta][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8220;.vc_custom_1557386419636{margin-bottom: 0px !important;}&#8220;]TNF\u03b1-Blocker sind Arzneistoffe, die in der Behandlung von entz\u00fcndlichen Erkrankungen wie Colitis ulcerosa, Morbus Crohn oder Rheuma Anwendung finden. Zu dieser Medikamentengruppe z\u00e4hlen unter anderem die Wirkstoffe Infliximab und Adalimumab.<\/p>\n","protected":false},"author":27,"featured_media":86935,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[239,252],"tags":[198],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TNF\u03b1-Blocker &amp; Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8<\/title>\n<meta name=\"description\" content=\"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TNF\u03b1-Blocker &amp; Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\" \/>\n<meta property=\"og:description\" content=\"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/\" \/>\n<meta property=\"og:site_name\" content=\"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-14T10:00:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-09T07:20:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/devclinical.r-biopharm.com\/wp-content\/uploads\/2015\/09\/TNFalpha-blocker-Therapie-Monitoring-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"690\" \/>\n\t<meta property=\"og:image:height\" content=\"252\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Janine Dege\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Janine Dege\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/\",\"url\":\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/\",\"name\":\"TNF\u03b1-Blocker & Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\",\"isPartOf\":{\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#website\"},\"datePublished\":\"2015-09-14T10:00:55+00:00\",\"dateModified\":\"2019-05-09T07:20:22+00:00\",\"author\":{\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"description\":\"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.\",\"breadcrumb\":{\"@id\":\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/devclinical.r-biopharm.com\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TNF\u03b1-Blocker &#038; Medikamenten-Monitoring\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#website\",\"url\":\"https:\/\/devdevclinical.r-biopharm.com\/\",\"name\":\"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/devdevclinical.r-biopharm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\",\"name\":\"Janine Dege\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g\",\"caption\":\"Janine Dege\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TNF\u03b1-Blocker & Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","description":"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"de_DE","og_type":"article","og_title":"TNF\u03b1-Blocker & Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","og_description":"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.","og_url":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/","og_site_name":"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","article_published_time":"2015-09-14T10:00:55+00:00","article_modified_time":"2019-05-09T07:20:22+00:00","og_image":[{"width":690,"height":252,"url":"https:\/\/devclinical.r-biopharm.com\/wp-content\/uploads\/2015\/09\/TNFalpha-blocker-Therapie-Monitoring-1.jpg","type":"image\/jpeg"}],"author":"Janine Dege","twitter_misc":{"Verfasst von":"Janine Dege","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/","url":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/","name":"TNF\u03b1-Blocker & Medikamenten-Monitoring (de) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","isPartOf":{"@id":"https:\/\/devdevclinical.r-biopharm.com\/#website"},"datePublished":"2015-09-14T10:00:55+00:00","dateModified":"2019-05-09T07:20:22+00:00","author":{"@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"description":"Pr\u00fcfung des Medikamentenspiegel von TNF\u03b1-Blockern zur Therapieoptimierung. Erfahren Sie mehr \u00fcber Medikamenten-Monitoring von Inflixmab und Adalimumb.","breadcrumb":{"@id":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/devclinical.r-biopharm.com\/de\/news\/tnf-blocker-medikamenten-monitoring\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/devclinical.r-biopharm.com\/de\/"},{"@type":"ListItem","position":2,"name":"TNF\u03b1-Blocker &#038; Medikamenten-Monitoring"}]},{"@type":"WebSite","@id":"https:\/\/devdevclinical.r-biopharm.com\/#website","url":"https:\/\/devdevclinical.r-biopharm.com\/","name":"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/devdevclinical.r-biopharm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f","name":"Janine Dege","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g","caption":"Janine Dege"}}]}},"_links":{"self":[{"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/53517"}],"collection":[{"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/comments?post=53517"}],"version-history":[{"count":4,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/53517\/revisions"}],"predecessor-version":[{"id":97037,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/53517\/revisions\/97037"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/media\/86935"}],"wp:attachment":[{"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/media?parent=53517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/categories?post=53517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/tags?post=53517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}